At the same time, drugmakers have come to rely on the U.S. market for the bulk of their revenue. In 2022, the U.S. accounted ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best ...

We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a ...

Large-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.

Today's pharmaceutical stocks are facing ... 150 percent to US$5.34 on February 6, following the company’s February 4 release of positive top-line results from its Phase 2 FIGHT DMD trial.

The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

However, J&J’s biggest moneymaker is its pharmaceutical segment. The company’s top-selling pharmaceutical products include autoimmune disease drug Stelara, blood cancer drugs Darzalex and ...

The US president vows "major" tariffs on imported medicines - raising fears of an increase in costs for Americans.